Autumn Research Update Meeting 2025
Our 2025 Autumn Research Update Meeting will take place once again at the renowned Royal Society of Medicine (RSM), Wimpole Street, London, on Monday 10 November, where guests can look forward to an engaging agenda featuring the latest updates from our funded research. Theme: Revolutionising...
Learn more
MIRO – A new biomarker for Parkinson’s?
Researchers at Stanford University in the US looking for new biomarkers of Parkinson’s, recently identified a protein called MIRO that in initial data very accurately identifies people with the condition. MIRO is a small protein that attaches to small structures inside our cells called mitochondria….
Tom Isaacs Award winner 2019 – Dr Tilo Kunath
Cure Parkinson’s and Van Andel Research Institute (VAI) have announced Dr. Tilo Kunath as the deserving 2019 winner of the ‘Tom Isaacs Award’. The nominations for the award this year were many and varied but the judges were unanimous in their choice of the winner. …
Phase 2 clinical trial to explore experimental K0706 in early Parkinson’s
Sun Pharma Advanced Research Company (SPARC) is conducting a phase 2 clinical trial to evaluate the safety and effectiveness of its experimental c-Abl inhibitor K0706 in people with early Parkinson’s disease. The trial, which is recruiting approximately 500 participants, will randomly assign participants to receive…
‘Voyager’ recruits patients for phase 2 gene therapy delivery
Voyager Therapeutics recently announced it is recruiting participants for the company’s phase 2 clinical trial testing the safety and effectiveness of the gene therapy VY-AADC02 in people with advanced Parkinson’s disease. Gene therapy is a technique that involves inserting new DNA into a cell using…
Evidence that Parkinson’s originates in the gut
A new study published in the journal ‘Neuron’ has found more evidence that Parkinson’s starts in the gut